2.1400
04-September-25 09:46:47
15 minutes delayed
Stocks
-0.1600
-6.96%
Today's range
2.1400 - 2.2500
ISIN
N/A
Source
NASDAQ
Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award
29 Sep 2022 05:00:01 By Nasdaq GlobeNewswire